Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 2 Carcinoma, Basal Cell 1

Interventions

Nivolumab 4 Biopsy 4 Specimen Handling 3 Ipilimumab 3 CTLA-4 Antigen 3 prednylidene 2 deltacortene 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Imiquimod 2 Celecoxib 2 talimogene laherparepvec 1 endonuclease V, phage T4 1 Tacrolimus 1 Sirolimus 1 Microarray Analysis 1 Isotretinoin 1 Deoxyribonuclease (Pyrimidine Dimer) 1 Chemoprevention 1 Biological Therapy 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Carcinoma, Basal Cell × Chemoprevention × Clear all

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡